Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy.
about
Zonisamide in the management of epilepsy in the elderlyProfile of once-daily zonisamide as monotherapy for treatment of partial seizures in adultsThe antiepileptic drug zonisamide inhibits MAO-B and attenuates MPTP toxicity in mice: clinical relevance.Clinically significant pharmacokinetic drug interactions between antiepileptic drugs.The management of refractory idiopathic epilepsies.Clinical pharmacology and therapeutic use of the new antiepileptic drugs.Zonisamide in pediatric epilepsy: review of the Japanese experience.Clinical experience with zonisamide monotherapy and adjunctive therapy in children with epilepsy at a tertiary care referral center.Zonisamide - a review of experience and use in partial seizures.Zonisamide in the treatment of epilepsy.Zonisamide in the treatment of epilepsy.Zonisamide: a review of its use in the management of adults with partial seizures.Zonisamide: a review of its use as adjunctive therapy in the management of partial seizures in pediatric patients aged ≥6 years.The safety and long-term efficacy of zonisamide as adjunctive therapy for focal epilepsy.Update on pharmacotherapy of myoclonic seizures.Treatment of Lennox-Gastaut syndrome: overview and recent findings.Contrasting effects of zonisamide and acetazolamide on amygdaloid kindling in rats.Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet.Pharmacokinetic study of zonisamide in patients undergoing brain surgery.
P2860
Q26820856-E2805F56-31E1-4538-AD47-D4E53CCA119CQ26995736-9BA380DA-E16A-49B7-B0D5-7DB145B454CDQ33615756-22D137F1-A2B7-441E-AA6C-27F056059504Q33668831-47F7E937-1616-45DD-8BF7-02F6BC8117D6Q34345026-975ABB99-DE0A-4C87-A9E3-5DBB4398B98BQ34541736-35538B36-1773-4D1C-B0C8-95D1EBE4E2FEQ34599818-6F990886-CDC3-47A1-B79D-51D8E4726631Q36099200-10C79EE7-C0F0-408E-9B0B-309A5D1E0321Q37165710-A5D8FDAC-0DE3-4816-A3ED-F448C48E8941Q37650321-FF3023FC-129A-44B8-978D-3A347259CFF2Q37941836-3C839385-B6C7-46CF-A526-8126AA8F1EE8Q38123123-E138272D-A027-4328-AA5F-2080DB37E373Q38199380-B0D32133-D73C-4841-8D81-BEF5D0D75F54Q38542947-5601E0DB-E6D4-43F4-8DCB-FBAB3406A24AQ39032456-6B09BB32-08B3-4762-9C89-E80020E3687FQ39990727-9371F031-B438-442F-BED0-79DD3EFBBC70Q43906032-FE65EFA7-50CA-4321-9144-96947E43DA9EQ44169569-F430E03C-F905-4785-A027-88D10ED92F63Q48842462-C462E9A7-157E-4E41-B487-B83B1B59B614
P2860
Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Zonisamide. A review of its ph ...... apeutic potential in epilepsy.
@en
type
label
Zonisamide. A review of its ph ...... apeutic potential in epilepsy.
@en
prefLabel
Zonisamide. A review of its ph ...... apeutic potential in epilepsy.
@en
P1433
P1476
Zonisamide. A review of its ph ...... apeutic potential in epilepsy.
@en
P2093
D H Peters
E M Sorkin
P304
P356
10.2165/00003495-199345050-00010
P577
1993-05-01T00:00:00Z
P6179
1019899086